References
- World Health Organization. Tuberculosis facts. Geneva, Switzerland: WHO; 2008.
- Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, . Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med 2008;177:348–55.
- Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350:2060–7.
- Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49(RR-6):1–51.
- Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15): 49–55.
- Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–84.
- QuantiFERON-TB Gold. Carnegie, Australia: Cellestis Ltd; 2009. Available at: http://www.cellestis.com/ (accessed December 2009).
- T.SPOT.TB Test. Abingdon, UK: Oxford Immunotec Ltd; 2009. Available at: http://www.oxfordimmunotec.com/ (accessed December 2009).
- Smith SG, Joosten SA, Verscheure V, Pathan A, McShane H, Ottenhoff T, . Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 2009;4:e7972.
- Lenders L, Meldau R, van Zyl-Smit R, Woodburne V, Maredza A, Cashmore T, . Comparison of same day versus delayed enumeration of TB-specific T cell responses. J Infect 2010;60:344–50.
- Lobue P. Provisional CDC recommendations for the use of interferon-gamma release assays to detect Mycobacterium tuberculosis infection in the United States. Program 50. Infectious Diseases Society of America, 47th Annual Meeting; October 28–November 1, 2009. Philadelphia, PA, USA; 2009.